Daily Stock List
Midwest Energy Emissions Corp. (MEEC)
Marketbeat, TopPennyStockMovers, Wall Street Resources, NBT Equities Research, Greenbackers, SeriousTraders, MissionIR, and PennyStocks24 reported on Midwest Energy Emissions Corp. (MEEC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Midwest Energy Emissions Corp. is an emerging leader in mercury emissions control technology for the worldwide coal-power industry. The Company develops and employs patented and proprietary technologies to remove mercury from coal-power plant emissions. Midwest Energy Emissions t centers on the delivery of mercury capture technologies to power plants and other industrial coal-burning units in North America, Europe, and Asia. The Company is based in Lewis Center, Ohio.
Midwest Energy Emissions uses patented technology that has been shown to achieve mercury removal levels compliant with the U.S. Environmental Protection Agency's (EPA) Mercury and Air Toxic Standards (MATS) rule, at a substantially lower cost and with less operational impact than methods now employed. This is while preserving the ability for customers to recycle and sell fly-ash for beneficial use.
Midwest’s proprietary SEA™ (Sorbent Enhancement Additive) technology delivers a flexible, tunable solution. It allows the global coal-power industry to easily comply with new, highly restrictive regulations on mercury air emissions. The SEA™ approach to mercury capture is precisely tailored for each application to complement a customer’s fuel type and boiler configuration for best results.
Midwest Energy Emissions announced this past January that it exercised its option to acquire in entirety all the patents related to mercury control from the Energy & Environmental Research Center Foundation (EERCF), in Grand Forks, North Dakota, for $2.5 million and 925,000 shares of common stock. The technology was originally developed at the University of North Dakota Energy & Environmental Research Center. The expectation is that closing of the transaction will occur by March 31, 2017, subject to approval by the U.S. Department of Energy.
Midwest Energy Emissions is adding a new product to its proven, cost-effective mercury capture program, which will cut mercury emissions by preventing scrubber reemission events. The design of the product is specifically for coal-fired power utilities with wet scrubbers to help remove mercury, and other metals from the scrubber.
Yesterday, Midwest Energy Emissions announced it has provided its financial results for Q4 and full year ended December 31, 2016. Total revenues in Q4 2016 rose 29 percent to $7.8 million, versus $6.1 million in Q4 of 2015. Total revenues for the full year 2016 were $32.3 million. This represents an increase of 156 percent versus revenue of $12.6 million in 2015.
Operating income in Q4 2016 improved considerably to $0.2 million, versus an operating loss of $1.5 million in Q4 2015. Operating income for the full year 2016 was $2.1 million, versus an operating loss of $3.7 million in 2015.
Net loss in Q4 2016 was $0.2 million, or ($0.00) per diluted share, versus a net loss of $7.1 million, or ($0.06) per diluted share in Q4 2015. Net loss for the full year 2016 was $16.9 million, or ($0.18) per diluted share, versus a net loss of $14.3 million, or ($0.13) per diluted share in 2015.
Midwest Energy Emissions Corp. (MEEC), closed Tuesday's trading session at $1.20, up 25.00%, on 1,600,986 volume with 797 trades. The average volume for the last 60 days is 75,855 and the stock's 52-week low/high is $0.312/$1.9308.
Cell MedX Corp. (CMXC)
The Observer, StockBlogs, SECFilings News, PennyStockLocks, ResearchOTC, StockRockandRoll, Daily Stock Motion, FatCat Stocks, Penny Pick Insider, Penny Stocks VIP, SMS Penny Picks, Wall Street Beauties, and WINNINGOTC reported previously on Cell MedX Corp. (CMXC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Cell MedX Corp focuses on the discovery, development, and commercialization of therapeutic and non-therapeutic products that promote general wellness and alleviate complications associated with medical conditions including, but not limited to, diabetes, Parkinson's disease, and high blood pressure. This is through developing technologies to help manage illness and related complications. The Company is at the vanguard of creating devices, which treat chronic and acute conditions for clinical and self-management care. An early development stage bio-technology company, Cell MedX is headquartered in Carson City, Nevada.
The Company manufactures and distributes medical devices powered by its proprietary, patented technology of low level current primarily for supporting chemical (pharmaceutical) treatments for diabetes. Cell MedX is making safe, results-oriented technologies combining electro-chemical applications and establishing new levels of treatment, called cellular medicine. Additionally, via its wholly-owned subsidiary, Avyonce Cosmedics, Inc., Cell MedX engages in the reselling and marketing of technology and equipment to the international wellness industry and providing continuing education to health care professionals.
Cell MedX’s goal is to release its initial lineup of commercial products. It will begin with its flagship product called ‘eBalance’, which works to improve the efficacy of the client’s existing medication regimes. The eBalance brand includes consumer product development and professional versions for use within medical facilities. The design of them are to address accelerated wound healing, abatement of diabetic neuropathies, improvement with glucose control, insulin resistance, and blood pressure.
The eBalance technology will form the foundation for a product line that will be available to assist in the management of diabetes mellitus (T1DM and T2DM) and its complications, as a professional clinic-based and a home use device. The eBalance Pro wellness device is an all-in-one, portable, and fully automated microcurrent delivery system.
This month, Cell MedX announced that it received an approval from the Ethics Review Board to start its observational clinical trial in Canada. Cell MedX engaged Nutrasource Diagnostics, Inc. (NDI) to launch the observational clinical trial of its inventive and proprietary technology branded under the trade name eBalance. The Trial will be conducted by Lead Investigator Dr. Richard Tytus at Hamilton Medical Research Group.
The intention of the Trial is to measure the impact of eBalance therapy as an adjunct treatment on HbA1c after three months of therapy in relation to the subject's baseline data and medical history. Furthermore, this month, Cell MedX announced that Dr. Richard Tytus and his team at Hamilton Medical Research Group have started screening for qualified subjects.
Today, Cell MedX announced that it completed its registration process with the U.S. Food and Drug Administration (FDA) and initiated an application process to receive FDA clearance for use of its eBalance device as a Class II non-exempt device. Moreover, Cell MedX announced that its ongoing clinical observational trial is advancing as expected. As of March 27, 2017, the group of study participants increased to 21, with 18 subjects having received their first eBalance treatments. Cell MedX expects that all 30 subjects will be initiated into the study by early April.
Cell MedX Corp. (CMXC), closed Tuesday's trading session at $0.418, up 16.11%, on 114,615 volume with 74 trades. The average volume for the last 60 days is 31,998 and the stock's 52-week low/high is $0.12/$0.4051.
ZIVO Bioscience, Inc. (ZIVO)
Ceocast News and RedChip reported earlier on ZIVO Bioscience, Inc. (ZIVO), and we report on the Company today, here at the QualityStocks Daily Newsletter.
ZIVO Bioscience, Inc.’s commitment is to the development and commercialization of nutritional compounds and bioactive molecules derived from its proprietary algal strains. ZIVO also engages in the development of natural bioactive compounds for use as dietary supplements and food ingredients, and biologically derived and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, particularly centered on autoimmune and inflammatory response modulation. ZIVO Bioscience is based in Keego Harbor, Michigan. The Company’s wholly-owned subsidiary is WellMetris, LLC.
ZIVO Bioscience is re-inventing its Company as a licensor of internally developed intellectual property (IP), which includes its proprietary algae cultures, in addition to IP secured through strategic acquisitions. The Company’s dedication is to the ideal of promoting health through using naturally occurring bioactive agents. These active ingredients are produced and processed to obtain the highest possible efficacy.
ZIVO Bioscience’s works to completely harness the beneficial effects of its natural bioactive agents and make them affordable and readily available in a useful and convenient form. The Company has more recently continued to concentrate almost exclusively on dairy cow applications for its proprietary algal biomass, extracts and any high-value bioactive compounds thereof. This is while developing the business case and production scale-up to cultivate and productize this algal biomass.
Concerning its platform strategy, ZIVO’s core IP comprises the algae culture itself, the patented process of producing that culture, and the bioactive compounds or molecules that can be extracted, and also the application of that culture or extract in supporting health maintenance and longevity. The Company’s intention is to approach the near-term markets first: animal applications, human food ingredients and human dietary supplements. This is while laying the groundwork for the more complex and longer-term opportunities in the medicinal and pharmaceutical market verticals.
In December 2016, ZIVO Bioscience and NutriQuest LLC announced the execution of a Letter of Intent (LOI) to jointly develop and test animal nutrition products derived from the proprietary ZIVO algae strain. Both companies have committed to enter into a definitive agreement, which grants NutriQuest a global license to market the products under its brand name. NutriQuest is a leader in animal health and nutrition solutions.
Last month, ZIVO Bioscience announced that it entered into a tolling agreement and technical services contract with Synthetic Genomics, Inc., (SGI) headquartered in La Jolla, California. ZIVO engaged SGI to produce biomass in sufficient quantity to satisfy the sample production demands for validation in an assortment of compliance studies and tests. These tests and studies have increased in number and scope since late April 2016 as ZIVO scaled up production to establish and test the parameters of commercialization.
ZIVO Bioscience, Inc. (ZIVO), closed Tuesday's trading session at $0.083, up 13.51%, on 91,285 volume with 11 trades. The average volume for the last 60 days is 33,604 and the stock's 52-week low/high is $0.021/$0.12.
DSG Global, Inc. (DSGT)
Epic Stock Picks, StockHideout, SMS Penny Picks, eliteotc.com, WININGOTC, Wall Street Beauties, PennyStockLocks, ResearchOTC, StockRockandRoll, The Observer, Stock Preacher, Penny Stocks Finder, SuperStockTips, Penny Stock Craze, InvestorSoup, Beacon Equity Research, and OTC Markets Group reported on DSG Global, Inc. (DSGT), and we also report on the Company, here at the QualityStocks Daily Newsletter.
DSG Global, Inc. is a technology development company with its corporate headquarters in Surrey, British Columbia. The Company engages in the design, manufacture, and marketing of fleet management solutions for the golf industry, as well as commercial, government, and military applications globally. DSG Global has historically focused on the golf industry.
Currently, DSG Global is branching into a number of new streams of revenue, via programmatic advertising, licensing and distribution. Additionally, it’s expanding into Commercial Fleet Management, and Agricultural applications. The Company lists on the OTCQB.
DSG Global provides patented electronic tracking systems and fleet management solutions to golf courses. These allow for remote management of the course's fleet of golf carts, turf equipment, and utility vehicles. DSG is best known for its advanced GPS TAG System for golf cart and turf equipment fleet management.
Golf course operators manage their fleet of golf carts, turf equipment, and utility vehicles remotely, utilizing DSG Global's SaaS technology and advanced GPS hardware. DSG has acquired Impact Tournament Solutions, along with Impact’s team of experts, to run the Tournament Solutions Division of DSG Global.
DSG Global has grown to become a leader in the Fleet Management category in the golf industry. The Company’s technology is installed in more than 10,000 vehicles on golf courses internationally. DSG has an installed base of daily-fee and resort golf courses. Its cart-mounted Touch® display screens seamlessly deliver banner advertisements and full-motion videos while on the golf course.
DSG Global has officially partnered with golf course video flyover company, STEADY MOTION, to bring the best interactive flyover videos to the golf sports industry. The flyover videos include professional, broadcast television quality audio narration, advanced color correction, and interactive course tours ready to undergo display on the DSG TOUCH screens and on golf course websites.
This past January, DSG Global announced that Talofofo Golf Club at Onward Beach Resort in Guam chose DSG Tag® systems for installation on their golf cart fleet. Moreover, this month, the Company announced it added two new Canadian golf courses to its list of over 300 leading golf facilities worldwide. DSG signed agreements to install the DSG Tag® Touch Systems on the fleet of golf carts at The Links at Penn Hills in Nova Scotia, and also Sandpiper Golf Course in the Fraser Valley of Greater Vancouver, British Columbia.
DSG Global, Inc. (DSGT), closed Tuesday's trading session at $0.15, up 46.19%, on 57,866 volume with 14 trades. The average volume for the last 60 days is 11,862 and the stock's 52-week low/high is $0.05/$1.78.
A.M. Castle & Co. (CASL)
We are highlighting A.M. Castle & Co. (CASL) today, here at the QualityStocks Daily Newsletter.
Established in 1890, A.M. Castle & Co. is a global distributor of specialty metal and supply chain solutions. The Company primarily serves the producer durable equipment, commercial aircraft, heavy equipment, industrial goods, construction equipment, and retail sectors. As a group, Castle and its affiliated companies operate out of 21 metals service centers located throughout North America, Europe and Asia. The Company specializes in the distribution of alloy and stainless steels; nickel alloys; aluminum, and carbon. A.M. Castle & Co. is based in Oak Brook, Illinois.
Clients use the Company when they are displeased by material availability issues; compelled to cut costs; and frustrated by price volatility. A.M. Castle’s customer base includes many Fortune 500 companies and thousands of medium and smaller sized firms spread across an array of industries.
A.M. Castle & Co. sources the broadest range of high-quality metals. This helps solve distribution, pricing, processing, and supply challenges locally and worldwide. Concerning its capabilities, Castle Metals offers Sawing; Plasma (electric arc) Cutting; Oxy-Fuel (flame) Cutting; Water Jet; Laser Cutting; and Shearing.
For the Aerospace sector, the Company helps aerospace and defense companies navigate complex requirements, schedules, and subcontractor networks. For the Oil & Gas sector, its metallurgical and supply chain expertise helps oil & gas customers meet unique specifications with stable supplies.
A.M Castle also customizes supply plans to customers across industrial sectors. This is from heavy equipment to semiconductors. Regarding Heat Treating, A.M. Castle uses a state-of-the-art, in-house heat treating facility to deliver custom properties to carbon and alloy steel products, and some stainless steels.
Concerning Machining, the Company offers CNC Machining, Trepanning, Boring, and Honing. Additional services provide by A.M. Castle include Bar Coding, Beveling, Chamfering, Chrome Plating, Deburring, Demagnetizing, and EDI ANSI X12 (EDI). EDI is used to transmit business transactions, including orders, confirmations and invoices, from one company's computer to another company's computer. Furthermore, additional services include Flattening, Forming/Drilling, Heat Stamping, Lathe Cutting, Line Marking, Packaging, Shot Blasting, and Straightening.
In November 2016, the Company announced that W.B. & Co. and affiliates, A.M. Castle & Co.’s largest and oldest shareholder group, increased ownership in A.M. Castle by purchasing Raging Capital’s entire equity ownership of 4,630,795 shares, bringing its equity ownership interest to roughly 35 percent of the Company’s common stock.
A.M. Castle & Co. (CASL), closed Tuesday's trading session at $0.30, up 15.38%, on 56,310 volume with 12 trades. The average volume for the last 60 days is 95,070 and the stock's 52-week low/high is $0.18/$0.55.
Dominovas Energy Corp. (DNRG)
The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.0007, up 16.67%, on 77,765,712 volume with 94 trades. The stock’s average daily volume over the past 60 days is 14,476,337 and its 52-week low/high is $0.0006/$0.028.
Dominovas Energy Corp. announced today that it has signed an agreement with Leveraged Green Energy (LGE) http://lgefund.net/ based in Washington DC which will facilitate financing, development and production of the RUBICON™ fuel cell energy generating system. LGE was established to identify, invest in, develop and commercialize clean energy technologies. LGE holds ownership stakes in green energy technology companies and has a significant portfolio of license rights from these companies.
Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.
At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.
In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.
Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer
Dominovas Energy Corp. Blog
Dominovas Energy Corp. News:
Dominovas Energy Obtains Partner to Facilitate Financing, Development and Production for RUBICON(TM) Fuel Cell Systems
Dominovas Energy Continues Discussions with Madagascar for Energy Projects
Dominovas Energy Secures Gas Supply for South Africa
Monaker Group, Inc. (MKGI)
The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $3.00, up 6.01%, on 5,466 volume with 16 trades. The stock’s average daily volume over the past 60 days is 7,921, and its 52-week low/high is $1.33/$4.35.
Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.
NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.
Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.
Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.
In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.
With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.
Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer
Monaker Group, Inc. Company Blog
Monaker Group, Inc. News:
Monaker Group to Present at the 29th Annual ROTH Conference, March 15, 2017
Monaker Group Appoints Robert Post to Board of Directors
Monaker Group Appoints Simon Orange to Board of Directors Appointment Advances Monaker's Plans for NASDAQ Listing
India Globalization Capital, Inc. (IGC)
The QualityStocks Daily Newsletter would like to spotlight India Globalization Capital, Inc. (NYSE: IGC). Today, India Globalization Capital, Inc. closed trading at $0.4145, up 3.70%, on 337,360 volume with 536 trades. The stock’s average daily volume over the past 60 days is 199,267, and its 52-week low/high is $0.19/$0.6701.
India Globalization Capital, Inc. (IGC) is a first mover in developing a portfolio of products using cannabis-based "combination therapies" for the treatment of pain and other conditions.
The national cost of health care due to pain ranges from $560 billion to $635 billion. In addition, the health care cost attributed to the abuse of prescription opioids, closely related to pain, is approximately $25 billion. IGC's patent filing (IGC-501) is a cannabis-based formulation addressing neuropathic and arthritic pain in joints and muscles using a variety of delivery techniques. The Company anticipates commencing clinical trials, and hopes that through its focus on combination therapy it can formulate and commercialize cannabinoid compounds as an alternative to long-term addictive opioid treatments.
The Company has also filed combination therapy formulations for the treatment of epilepsy and cachexia. About 50 million people worldwide are affected by epilepsy and about 1.3 million in the U.S. experience cachexia associated with cancer, MS, Parkinson's, HIV/AIDS and other progressive illnesses. Cancer-induced anorexia/cachexia is responsible for 20% of all cancer deaths. IGC-502 indicated for seizures and IGC-504 indicated for cachexia are unique combination therapies that, if proven out by clinical trials, are expected to treat medical refractory epilepsy and eating disorders respectively, with lower side effects than conventional mono therapies.
IGC's strategy is exciting and unique in that it is aiming to become a leader in the phytocannabinoid-based combination therapy specialty pharmaceutical sector. This first mover advantage can potentially be formidable as it begins clinical trials and further builds its patent portfolio. "The development of combination therapies utilizing cannabis represents a large, unique opportunity in this emerging specialty-pharmaceutical sector. Securing FDA approval for combination therapy is believed to be significantly faster and less expensive than new drug applications. As a result, we believe that we can bring our cannabis-based pharmaceutical products to market in both an expeditious and cost-effective manner," stated Ram Mukunda, CEO.
IGC has recently exited its legacy businesses and currently holds international investments in land and in a hotel project. An impressive and experienced team, led by Mr. Ram Mukunda, CEO, directs IGC.
Mr. Mukunda holds degrees in Electrical Engineering and Mathematics from the University of Maryland (UMD). He founded and served as Chairman and CEO of Startec Global Communications, an international telecommunications carrier focused on providing voice over Internet protocol (VOIP) services to emerging economies. Startec, the first pure play international long distance carrier, went public on NASDAQ. He has won a number of awards, including the 2013 University of Maryland International Alumnus of the year award. Mr. Mukunda serves as an Emeritus member on the Board of Visitors at the University of Maryland, School of Engineering, and has served as Council Member at Harvard's Kennedy School of Government, Belfer Center of Science and International Affairs. Mr. Mukunda and Dr. Krishna are the originators of all the IGC patent filings.
Dr. Ranga Krishna, Senior Advisor, is a Board Certified Neurologist with a sub specialty in Epilepsy surgery. He is the Director of Neurology at the New York Community Hospital affiliated with New York Presbyterian Weil Cornell Medical College and the Director of Stroke Service at the New York Community Hospital affiliated with New York Presbyterian Weil Cornell Medical College. He is the Medical Director and Chairman of Total Neuro Care, P.C. He is CEO of International Pharma Trials, Inc., which assists U.S. pharmaceutical companies perform Phase II clinical trials. Dr. Krishna is a member of several organizations, including the American Academy of Neurology and the Medical Society of the State of New York. He is also a member of the Medical Arbitration panel for the New York State Workers' Compensation Board and a Founding Member of the New York State Pain Society. Dr. Krishna was trained at New York's Mount Sinai Medical Center (1991-1994) and New York University (1994-1996). Dr. Krishna and Mr. Mukunda are the originators of all the IGC patent filings. Disclaimer
India Globalization Capital, Inc. Company Blog
India Globalization Capital, Inc. News:
IGC Files Patent for Cannabis-based Combination Therapy for Treatment of Eating Disorders
NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) CEO Featured in Benzinga Article
IGC Announces Third Quarter Financial Results
One Step Vending Corp. (KOSK)
The QualityStocks Daily Newsletter would like to spotlight One Step Vending Corp. (KOSK). Today, One Step Vending Corp. closed trading at $0.02321, up 1.75%, on 1,585,963 volume with 58 trades. The stock’s average daily volume over the past 60 days is 1,097,012, and its 52-week low/high is $0.0026/$0.17.
One Step Vending Corp. (KOSK) is focused on growing through acquisitions and cooperative agreements with companies that have potential and capabilities of achieving sustainable growth and rapidly capturing market share. The company provides financing and operational business support while also helping build key growth strategies. Key business sectors actively targeted include food and refreshment services, self-checkout systems and mobile vending machines.
Corporate Refreshment Services Micro Markets Inc., a subsidiary of One Step Vending, is a self-checkout retailer that offers a wide range of food and beverages. With more than 150,000 units supplied to customers in the last twelve months, the company is experiencing triple-digit growth. Regardless if a traditional vending machine or the high-tech micro market is chosen, the location's patrons enjoy gourmet market deliciousness and quick market convenience.
Mainly targeting the office environment, the micro markets offer a fresh market-grab and go-food concept that doesn't cost the business anything to host. Each micro market can be customized for any size or look and feature an easy-to-use touch screen interface so anyone can easily shop, scan and pay for their items. Once installed, employees benefit from a diverse menu that includes healthy snacks, real food, classic vending favorites and much more.
The team behind this concept has been committed to staying at the forefront of vending technology for 15 years. By replacing traditional vending machines with micro markets, they experienced up to five times greater revenue in large accounts. Today, the groundwork is laid with unique capabilities and proven execution strategies.
With Corporate Refreshment Services setting the example, One Step Vending's mission is to support thousands of businesses in the realization of their business goals by delivering experiences that enrich and nourish. Fostering a winning network of associates and partners and building mutually loyalty and trust is core to the company's growth strategy. Disclaimer
One Step Vending Corp. Company Blog
One Step Vending Corp. News:
One Step Vending Corp. Installs Four New Micro Markets at a San Diego Pharmaceutical Facility
One Step Vending Corp. Installs Micro Market at Cushman Wakefield
One Step Vending Corp. Seeks Savvy Corporate Partners and Micro Market Investors for Mutually Beneficial Sales Growth Opportunities
eXp World Holdings, Inc. (EXPI)
The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $3.709, up 3.03%, on 2,600 volume with 14 trades. The stock’s average daily volume over the past 60 days is 12,286, and its 52-week low/high is $1.04/$5.84.
eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.
Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.
Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.
Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer
eXp World Holdings, Inc. Company Blog
eXp World Holdings, Inc. News:
eXp World Holdings to Present at The MicroCap Conference on April 4th in New York
eXp Realty Reaches 3,000 Agent Milestone
eXp World Holdings to Present at Annual ROTH Conference
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- ChineseInvestors.com, Inc. (CIIX) Alan Klitenic, Director of Investor Relations for ChineseInvestors.com, Discusses Recent CIIX News and Industry Trends in a New Audio Interview with SmallCapVoice.com
- Dominovas Energy Corp. (DNRG) Obtains Partner to Facilitate Financing, Development and Production for RUBICON(TM) Fuel Cell Systems
- eXp World Holdings, Inc. (EXPI) to Present at The MicroCap Conference on April 4th in New York
- GreenStone Healthcare Corp. (GRST) Buys Canadian Real Estate Assets, Sells Canadian Addiction Treatment Business, and Acquires Addiction Treatment Business in Florida
- India Globalization Capital, Inc. (NYSE: IGC) Files Patent for Cannabis-based Combination Therapy for Treatment of Eating Disorders
- InMed Pharmaceuticals Inc. (IMLFF) Unique Approach Featured in Forbes -- CFN Media
- MGX Minerals Inc. (MGXMF) Acquires 110,000 Acres of Paradox Basin, Utah Oil and Gas Leases
- Monaker Group, Inc. (MKGI) to Present at the 29th Annual ROTH Conference, March 15, 2017
- National Waste Management Holdings, Inc. (NWMH) Expands Territory with Acquisition of Burts Refuse, LLC
- One Step Vending Corp. (KOSK) Installs Four New Micro Markets at a San Diego Pharmaceutical Facility
- ORHub, Inc. (ORHB) NetworkNewsWire Announces Publication of Discussion on the Value of IT & Big Data Analytics for the Health Care Industry
- ProBility Media Corp. (PBYA) Files 10Q, Reports Third Consecutive Quarter of Revenue Growth
- Players Network (OTCQB: PNTV) Featured on MoneyTV with Donald Baillargeon, 2/17
- Singlepoint, Inc. (SING) Executes on Cannabis Acquisition Strategy -- CFN Media
- Stealth Technologies, Inc. (STTH) Announces 5 New Products